Pharma Sector Forecast: ICRA Projects 7-9% Revenue Growth for FY26 Amidst US Market Challenges
Summary The Indian pharmaceutical sector is projected to achieve a moderate revenue growth of 7โ9 per cent in fiscal year 2026 (FY26), according to ratings agency ICRA, despite facing significant challenges in its largest export market, the United States. The forecast reflects a complex global and domestic landscape where regulatory uncertainties, pricing pressures, and trade-related […]
